HIV infection has become a chronic disease in pediatric patients, with the potential for longer
term survival and exposure to combination antiretroviral therapy for two decades longer than …

Background: The aim of our study was to assess the association between HIV viral load (HIV-
VL) and metabolic syndrome (MS) in a cohort of HIV-infected patients. Methods: This is a …

Objective: To assess the prevalence of metabolic syndrome and its components in HIV
infected individuals assisted in a specialized health center in a municipality in the state of …

Aims and Objectives: To assess the prevalence of metabolic syndrome (MetS) in human
immunodeficiency virus (HIV) positive patients. Prevalence of MetS was compared in …

Objectives To estimate prevalence of body fat redistribution and dyslipidaemia in HIV-
infected children and to assess associated risk factors, ultimately to inform the definition of …

The introduction of highly active antiretroviral therapy (HAART) for the treatment of acquired
immunodeficiency syndrome (AIDS) has resulted in greater survival of patients infected with …

Background: Noncommunicable diseases are common among chronically infected patients
with HIV in the developed world, but little is known about these conditions in African cohorts …

Background. Comorbidities in people living with HIV (PLWH) represent a major clinical
challenge today, and metabolic syndrome (MTBS) is one of the most important. Objective …

Background: HIV-1 can induce disturbances in adipose tissue in infected subjects through
the effects of some of its proteins or inflammation. It is not known whether this also takes …

Background: HIV-infected adults with lipodystrophy, characterized by excess accumulation
of intra-abdominal adipose tissue (IAT), showed impaired growth hormone (GH) secretion …